The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Disease-driven symptoms and response to chemotherapy in treatment-naive patients with advanced non-small cell lung cancer (NSCLC).
Desiree Jones
No relevant relationships to disclose
Elisabeth G. Vichaya
No relevant relationships to disclose
Xin Shelley Wang
No relevant relationships to disclose
Tito R. Mendoza
No relevant relationships to disclose
Gary M. Mobley
No relevant relationships to disclose
Charles Lu
No relevant relationships to disclose
Charles S. Cleeland
No relevant relationships to disclose